Skip to main content
SpringerLink
Log in

New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies

  • Leading Article
  • Published:
Blut Aims and scope Submit manuscript

Summary

Until recently only tests with a limited specificity were available for the assessment of the products of activated coagulation and/or fibrinolysis. Those assays were based on polyclonal antibodies, which crossreact with fibrinogen, and as a consequence they were performed on serum samples i.e. after removal of fibrinogen by clotting. Serum preparation, however, is a notorious source of artefactually high or low levels of fibrin(ogen) degradation products, and is not suitable for the determination of coagulation products. Recently, highly specific monoclonal antibodies (MoAb's) have been developed, the majority of which do not crossreact with fibrinogen. This has enabled new strategies to be developed, i.e. assays using these MoAb's on plasma samples. Furthermore, the new assays can discriminate between (individual) fibrin and fibrinogen degradation products, and coagulation products can be assessed in the same plasma samples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brass EP, Forman WB, Edwards RV, Lindan O (1976) Fibrin formation: the role of the fibrinogen-fibrin monomer complex. Thromb Haemost 36: 36–48

    Google Scholar 

  2. Connaghan DG, Francis DW, Ryan DH, Marder VJ (1986) Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products. Am J Clin Pathol 86: 304–310

    Google Scholar 

  3. Doolittle RF (1973) Structural aspects of the fibrinogen to fibrin conversion. Adv Protein Chem 27: 1–109

    Google Scholar 

  4. Doolittle RF (1981) Fibrinogen and fibrin. Sci Am 245: 92–101

    Google Scholar 

  5. Elms MJ, Bunce JH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN (1983) Measurement of crosslinked fibrin degradation products — An immunoassay using monoclonal antibodies. Thromb Haemost 50: 591–594

    Google Scholar 

  6. Gaffney PJ, Perry MJ (1985) “Giant” fibrin fragments and thrombosis. Thromb Haemost 54: 931 (abstract)

    Google Scholar 

  7. Gaffney PJ, Perry MJ (1985) Unreliability of current serum fibrin degradation products (FDP) assays. Thromb Haemost 53: 301–302

    Google Scholar 

  8. Gaffney PJ, Creighton LC, Harris R, Perry MJ (1986) Monoclonal antibodies (MABS) to crosslinked fibrin fragments. Their characterization and potential clinical use. In: Müller-Berghaus G, et al. (eds.) Fibrinogen and its Derivatives. Biochemistry, Physiology and Pathophysiology. Excerpta Medica, Amsterdam, pp 273–284

    Google Scholar 

  9. Graeff H, Hafter R, von Hugo R (1979) On soluble fibrinogen-fibrin complexes. Thromb Res 16: 575–576

    Google Scholar 

  10. Graeff H, Hafter R (1982) Detection and relevance of crosslinked fibrin derivatives in blood. Semin Thromb Haemost 8: 57–68

    Google Scholar 

  11. Haverkate F, Timan G, Nieuwenhuizen W (1979) Anticlotting properties of fragments D from human fibrinogen and fibrin. Eur J Clin Invest 9: 253–255

    Google Scholar 

  12. Hermans J, McDonagh J (1982) Fibrin: structure and interactions. Semin Thromb Haemost 8: 11–24

    Google Scholar 

  13. Hoegee-de Nobel E, Voskuilen M, Briët E, Brommer EJP, Nieuwenhuizen W (1988) A monoclonal antibody-based quantitative enzyme immuno assay for the determination of plasma fibrinogen concentrations. Thromb Haemost (in press)

  14. Holm B, Nilsen DWT, Kierulf P, Godal HC (1985) Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res 37: 165–176

    Google Scholar 

  15. Koopman J, Haverkate F, Koppert PW, Nieuwenhuizen W, Brommer EJP, van der Werf WGC (1987) New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Lab Clin Med 109: 75–84

    Google Scholar 

  16. Koppert PW, Huijsmans CMG, Nieuwenhuizen W (1985) A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A. Blood 66: 503–507

    Google Scholar 

  17. Koppert PW, Koopman J, Haverkate F, Nieuwenhuizen W (1986) Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising Bβ 54–118) in degradation products of fibrin and of fibrinogen. Blood 68: 437–441

    Google Scholar 

  18. Koppert PW, Kuipers W, Hoegee-de Nobel E, Brommer EJP, Koopman J, Nieuwenhuizen W (1987) A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma. Thromb Haemost 57: 25–28

    Google Scholar 

  19. Koppert PW, Hoegee-de Nobel E, Nieuwenhuizen W (1988) A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thromb Haemost 59: 310–315

    Google Scholar 

  20. Marder VJ, Shulman NR (1969) High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. J Biol Chem 244: 2120–2124

    Google Scholar 

  21. Merskey C, Lalezazi P, Johnson AJ (1969) A rapid simple sensitive method for measuring fibrinolytic split products in human serum. Proc Soc Exp Biol Med NY 131: 871–875

    Google Scholar 

  22. Mirshahi M, Soria J, Soria C, Perrot J-Y, Boucheix C (1986) A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody. Thromb Res 44: 715–728

    Google Scholar 

  23. Mosesson MW, Galanakis DK, Finlayson JS (1974) Comparison of human plasma fibrinogen subfractions and early plasmic fibrinogen derivatives. J Biol Chem 249: 4656–4664

    Google Scholar 

  24. Müller-Berghaus G, Scheefers-Borchel U, Fuhge P, Eberle R, Heimburger N (1985) Detection of fibrin in plasma by a monoclonal antibody against the amino-terminus of the alpha-chain of fibrin. Scand J Lab Invest Suppl 178, 45: 145–151

    Google Scholar 

  25. Nieuwenhuizen W, Gravesen M (1981) Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen, produced by plasmin (fragments X). Biochim Biophys Acta 668: 81–88

    Google Scholar 

  26. Nieuwenhuizen W, Voskuilen M, Hermans J (1982) Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y). Biochim Biophys Acta 708: 313–316

    Google Scholar 

  27. Nieuwenhuizen W (1987) A double blind comparative study of six monoclonal antibody-based plasma assays for fibrinogen derivatives. In: Lowe GDO, Douglas JT, Forbes CD, Henschen A (eds) Fibrinogen 2, Biochemistry, Physiology and Clinical Relevance. Excerpta Medica, Amsterdam, pp 181–186

    Google Scholar 

  28. Nieuwenhuizen W, Hoegee-de Nobel E, Voskuilen M (1988) A monoclonal antibody-based enzyme immunoassay for intact fibrinogen. Fibrinolysis 2: 222 (abstract)

    Google Scholar 

  29. Niewiarowski S, Stewart GJ, Marder VJ (1970) Formation of highly ordered polymers from fibrinogen and fibrin degradation products. Biochim Biophys Acta 221: 326–341

    Google Scholar 

  30. Philips HM (1981) Isolation of six homogeneous preparations of high molecular weight and low molecular weight fibrinogen. Can J Biochem 59: 332–342

    Google Scholar 

  31. Rylatt DB, Blake AS, Gottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AM, Elms M, Bunce J, Webber A, Wyatt D, Bundesen PG (1983) An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31: 767–778

    Google Scholar 

  32. Scheefers-Borchel U, Müller-Berghaus G, Fuhge P, Eberle R, Heimburger N (1985) Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide. Proc Natl Acad Sci USA 82: 7091–7095

    Google Scholar 

  33. Scheefers-Borchel U, Müller-Berghaus G, Fuhge P, Heimburger N (1986) Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic hexapeptide representing the amino-terminus of the alpha-chain of fibrin. In: Lane DA et al. (eds) Fibrinogen, Fibrin formation and Fibrinolysis. Walter de Gruyter, Berlin, pp 253–260

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gaubius Institute Netherlands Organization for Applied Scientific Research, P.O. Box 612, NL-2300 AP, Leiden, The Netherlands

    W. Nieuwenhuizen

Authors
  1. W. Nieuwenhuizen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nieuwenhuizen, W. New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies. Blut 57, 285–291 (1988). https://doi.org/10.1007/BF00320354

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00320354

Key words

Search

Navigation